Precigen, Inc. Files Proxy Statement Amendment
Ticker: PGEN · Form: DEFA14A · Filed: May 16, 2025 · CIK: 1356090
| Field | Detail |
|---|---|
| Company | Precigen, Inc. (PGEN) |
| Form Type | DEFA14A |
| Filed Date | May 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance
TL;DR
Precigen filed proxy docs, check for shareholder updates.
AI Summary
Precigen, Inc. filed a Definitive Additional Materials proxy statement on May 16, 2025. This filing relates to the company's proxy statement and is an amendment to previous filings. The company is incorporated in Virginia and its fiscal year ends on December 31.
Why It Matters
This filing indicates ongoing corporate governance and shareholder communication activities for Precigen, Inc., which is important for investors to stay informed about company decisions and management.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate actions that would immediately impact risk.
Key Players & Entities
- PRECIGEN, INC. (company) — Registrant
- 0001140361-25-019471 (filing_id) — Accession Number
- 20250516 (date) — Filing Date
- INTREXON CORP (company) — Former Company Name
FAQ
What type of filing is this?
This is a Definitive Additional Materials proxy statement (DEFA14A) filed by Precigen, Inc.
When was this filing made?
The filing was made on May 16, 2025.
What is the company's primary business?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
What is Precigen, Inc.'s business address?
Precigen, Inc.'s business address is 20374 Seneca Meadows Parkway, Germantown, MD 20876.
Has the company changed its name previously?
Yes, the former company name was INTREXON CORP, with a date of name change on March 13, 2006.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 16, 2025 regarding PRECIGEN, INC. (PGEN).